HighTower Advisors »

Plus Therapeutics shares owned by HighTower Advisors

Quarter-by-quarter ownership of Plus Therapeutics (PSTV) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Plus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Plus Therapeutics held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Plus Therapeutics by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.2k 16k 0.51

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Vanguard Index Fds Growth Etf (VUG)

View all positions for HighTower Advisors

Top funds holding Plus Therapeutics

Vanguard Group
BlackRock
Geode Capital Management
Jane Street
UBS Group
Virtu Financial
State Street Corporation
Northern Trust
XTX Topco
Two Sigma Securities
Dagco
Kestra Advisory Services
Ashton Thomas Private Wealth
HighTower Advisors
Cambridge Investment Research Advisors

View all funds holding Plus Therapeutics